Cat grooming & Cat health

| Subcribe via RSS

Oral Cancer in Cats

August 17th, 2010 | Comments Off | Posted in computed tomography, squamous cell carcinoma
a href="http://www.ncbi.nlm.nih.gov/pubmed/20113245"Gendler A, Lewis JR, Reetz JA, et al. Computed tomographic features of oral squamous cell carcinoma in cats: 18 cases (2002-2008). J Am Vet Med Assoc 2010;236:319-325./abr / br / This is a retrospective study of 18 cats with a diagnosis of oral squamous cell carcinoma (OSCC). The objective was to describe the computed tomographic (CT) features of OSCC in cats and identify any imaging characteristics associated with survival time. Oral tumors comprise 3% to 10% of all neoplasms of cats with SCC, accounting for 61.2% to 76.2% of those oral tumors. OSCC is a locally invasive disease that is considered to have a low potential for metastasis. On oral examination under general anesthesia, masses were most frequently found in the sublingual or lingual region (7/18) and in the maxilla (5/18). The study enabled identification of several common CT features of OSCC in cats. One finding included marked heterogenous contrast enhancement of masses and adjacent osteolysis on images of sublingual and maxillary mucosal images. CT may be used to define mass extension accurately and facilitate lymph node extension in cats with OSCC, but these features did not correlate with survival time. Soft palate lesions were noted on oral examination 4 times more frequently as on CT images. These findings indicate that a thorough oral examination is particularly important for evaluation of patients with small lesions or those localized to the soft palate, tonsils, or pharynx. CT imaging of patients with head and neck neoplasia is therefore of value for defining the extent of a mass, the involvement of adjacent structures, and the identification of regional metastasis. [VT]br / br / bRelated articles:/bbr / a href="http://www.ncbi.nlm.nih.gov/pubmed/18289304"Wypij JM, Fan TM, Fredrickson RL, et al. In vivo and in vitro efficacy of zoledronate for treating oral squamous cell carcinoma in cats. J Vet Intern Med 2008;22:158-163./abr / br / More on cat health: a href="http://www.winnfelinehealth.org/Health.html"Winn Feline Foundation Library/abr / a href="http://www.facebook.com/WinnFelineFoundation"Join us on Facebook/abr / a href="http://www.twitter.com/WinnFeline"Follow us on Twitter/adiv class="blogger-post-footer"Providing expert cat health information and supporting cat health research since 1968.img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/1170470470666539402-6977313447487255264?l=winnfelinehealth.blogspot.com' alt='' //divdiv class="feedflare" a href="http://feeds.feedburner.com/~ff/CatHealthNewsFromTheWinnFelineFoundation?a=CdHOj7C_tUU:tiix0LI7MFE:yIl2AUoC8zA"img src="http://feeds.feedburner.com/~ff/CatHealthNewsFromTheWinnFelineFoundation?d=yIl2AUoC8zA" border="0"/img/a a href="http://feeds.feedburner.com/~ff/CatHealthNewsFromTheWinnFelineFoundation?a=CdHOj7C_tUU:tiix0LI7MFE:UT3xtbGYFzA"img src="http://feeds.feedburner.com/~ff/CatHealthNewsFromTheWinnFelineFoundation?d=UT3xtbGYFzA" border="0"/img/a a href="http://feeds.feedburner.com/~ff/CatHealthNewsFromTheWinnFelineFoundation?a=CdHOj7C_tUU:tiix0LI7MFE:qj6IDK7rITs"img src="http://feeds.feedburner.com/~ff/CatHealthNewsFromTheWinnFelineFoundation?d=qj6IDK7rITs" border="0"/img/a a href="http://feeds.feedburner.com/~ff/CatHealthNewsFromTheWinnFelineFoundation?a=CdHOj7C_tUU:tiix0LI7MFE:F7zBnMyn0Lo"img src="http://feeds.feedburner.com/~ff/CatHealthNewsFromTheWinnFelineFoundation?i=CdHOj7C_tUU:tiix0LI7MFE:F7zBnMyn0Lo" border="0"/img/a a href="http://feeds.feedburner.com/~ff/CatHealthNewsFromTheWinnFelineFoundation?a=CdHOj7C_tUU:tiix0LI7MFE:V_sGLiPBpWU"img src="http://feeds.feedburner.com/~ff/CatHealthNewsFromTheWinnFelineFoundation?i=CdHOj7C_tUU:tiix0LI7MFE:V_sGLiPBpWU" border="0"/img/a a href="http://feeds.feedburner.com/~ff/CatHealthNewsFromTheWinnFelineFoundation?a=CdHOj7C_tUU:tiix0LI7MFE:oCFASsrFxfc"img src="http://feeds.feedburner.com/~ff/CatHealthNewsFromTheWinnFelineFoundation?d=oCFASsrFxfc" border="0"/img/a /divimg src="http://feeds.feedburner.com/~r/CatHealthNewsFromTheWinnFelineFoundation/~4/CdHOj7C_tUU" height="1" width="1"/

Feline Squamous Cell Carcinoma: Role of Papillomavirus

November 2nd, 2009 | Comments Off | Posted in papillomavirus, squamous cell carcinoma
Munday, J.S., M. Dunowska, and S. De Grey, Detection of two different papillomaviruses within a feline cutaneous squamous cell carcinoma: case report and review of the literature. N Z Vet J, 2009. 57(4): p. 248-51.

Squamous cell carcinomas (SCC) are among the most common malignant skin cancers of cats. There is evidence that papillomaviruses promote SCC development on sun-exposed areas in humans. About 100 papillomaviruses are known in humans, but only a few in dogs and cats. Previous reports have identified papillomaviruses in a certain proportion of canine SCC. This paper describes the identification (using PCR) of viral DNA from two distinct papillomaviruses in an invasive SCC on the nose of a 15-year-old cat. One of the two viruses has never been described before. It is also the first time that multiple papillomaviruses have been detected in a single cancerous lesion in a cat. This finding supports the association between papillomaviruses and SCC in cats. If papillomaviruses influence the development of feline SCC, new approaches to treatment may be possible. [MK]
>> PubMed Abstract

Related articles:
Munday, J.S., et al., Detection of papillomaviral sequences in feline Bowenoid in situ carcinoma using consensus primers. Vet Dermatol, 2007. 18(4): p. 241-5.
>> PubMed Abstract

Zaugg, N., et al., Detection of novel papillomaviruses in canine mucosal, cutaneous and in situ squamous cell carcinomas. Vet Dermatol, 2005. 16(5): p. 290-8.
>> PubMed Abstract

More on cat health: Winn Feline Foundation Library
Join us on Facebook
Follow us on Twitter

Feline Papillomavirus

July 15th, 2009 | Comments Off | Posted in papillomavirus, squamous cell carcinoma
Munday, J. S., L. Howe, et al. (2008). "Detection of papillomaviral DNA sequences in a feline oral squamous cell carcinoma." Res Vet Sci 86(2): 359-361.

Oral squamous cell carcinomas constitute 7.5% of all feline cancers, and often lead to death in affected cats. In humans, these tumors are associated with papillomavirus in about 25% of the cases. To investigate the association of papillomavirus with feline oral tumors, 40 oral lesions (20 cancerous, 20 non-cancerous) were examined for viral DNA. Papillomaviral DNA was detected in one oral tumor, but not in any non-cancerous lesion. Finding viral DNA in only one tumor did not indicate a causal relationship. The finding of viral DNA does however indicate additional research into the carcinogenic potential of these viruses in cats is warranted; the carcinogenic potential of papillomaviruses in general and the finding here of viral DNA in a feline oral tumor hints at a possible role. [MK]
>> PubMed Abstract

Related articles:
Munday, J. S., M. Kiupel, et al. (2007). "Detection of papillomaviral sequences in feline Bowenoid in situ carcinoma using consensus primers." Vet Dermatol 18(4): 241-5.
>> PubMed Abstract

Sundberg, J., M. Van Ranst, et al. (2000). "Feline papillomas and papillomaviruses." Vet Pathol 37(1): 1-10.
>> PubMed Abstact

More on cat health: Winn Feline Foundation Library
Join us on Facebook

Squamous Cell Carcinomas in Cats

November 25th, 2008 | Comments Off | Posted in cancer, photodynamic therapy, squamous cell carcinoma
Bexfield, N. H., A. J. Stell, et al. (2008). "Photodynamic Therapy of Superficial Nasal Planum Squamous Cell Carcinomas in Cats: 55 Cases." Journal of Veterinary Internal Medicine 22(6): 1385-1389.

Squamous cell carcinoma (SCC) is a common skin tumour found in cats. It often affects areas that are non-pigmented and with little hair, such as the nose, eyelids, and ears. Conventional therapies for SCC include surgery and radiation. Photodynamic therapy (PDT) is a cancer therapy that uses visible light to activate photosensitizer agents that localize in the target tissue. The photosensitizing agent 5-ALA can be administered topically, and has previously been evaluated for feline cancer therapy in a small study. Fifty-five cats with SCC of the nose referred to the Queen's Veterinary School Hospital (University of Cambridge, UK) were enrolled in the prospective study. The 5-ALA cream was applied topically every 30 minutes for a period of 6-8 hours. The cats were lightly sedated and medicated for pain, and all wore an Elizabethan collar. Illumination of the lesions was performed with light emitting diodes while the patients were under general anesthesia. Cats were reassessed one month after PDT. Outcomes were defined as complete response, partial response, or no response. Ninety-six percent of the cats responded to therapy, with 85% having a complete response. However, there was a recurrence rate of 51% at a median interval of 157 days. Although PDT does not lead to a complete remission in all SCC cases, it has the benefit of being safe, well tolerated, and cosmetically acceptable.
>> PubMed Abstract

Related articles:
Hammond, G. M., I. K. Gordon, et al. (2007). "Evaluation of strontium Sr 90 for the treatment of superficial squamous cell carcinoma of the nasal planum in cats: 49 cases (1990-2006)." J Am Vet Med Assoc 231(5): 736-41.
>> PubMed Abstract

More on cat health: Winn Feline Foundation Library